RT @ARD_BMJ: Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Po
Tweet Content
Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Post-hoc analysis from Discover1&2 studies (Prof P Helliwell). #OP0054. #EULAR2020, >GF
Show on Archive Page
On
Display in Search Results
On